Medlab Clinical Limited Price Chart
Medlab Clinical Limited MDC.XA Financial and Trading Overview
| Medlab Clinical Limited stock price | 6.9 AUD |
| Previous Close | 6.9 AUD |
| Open | 6.9 AUD |
| Bid | 6.51 AUD x N/A |
| Ask | 6.9 AUD x N/A |
| Day's Range | 6.9 - 6.9 AUD |
| 52 Week Range | 6.9 - 6.9 AUD |
| Volume | 42 AUD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.104061 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.031 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MDC.XA Valuation Measures
| Enterprise Value | 10.97M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.9497033 |
| Enterprise Value/Revenue | 7.139 |
| Enterprise Value/EBITDA | -0.904 |
Trading Information
Medlab Clinical Limited Stock Price History
| Beta (5Y Monthly) | 1.104061 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 15.27% |
| 52 Week High | 6.9 AUD |
| 52 Week Low | 6.9 AUD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
MDC.XA Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 1.5M |
| Short Ratio | N/A |
| % Held by Insiders | 43.74% |
| % Held by Institutions | 1.02% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -845.12% |
| Gross Margin | 78.11% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.76% |
| Return on Equity (ttm) | -74.054% |
Income Statement
| Revenue (ttm) | 1.54M AUD |
| Revenue Per Share (ttm) | 0.67 AUD |
| Quarterly Revenue Growth (yoy) | 124.40% |
| Gross Profit (ttm) | 1.2M AUD |
| EBITDA | -12133499 AUD |
| Net Income Avi to Common (ttm) | -8322071 AUD |
| Diluted EPS (ttm) | -0.031 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.54M AUD |
| Total Cash Per Share (mrq) | 2.43 AUD |
| Total Debt (mrq) | 1.08M AUD |
| Total Debt/Equity (mrq) | 13.95 AUD |
| Current Ratio (mrq) | 3.737 |
| Book Value Per Share (mrq) | 3.539 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9410955 AUD |
| Levered Free Cash Flow (ttm) | -8166807 AUD |
Profile of Medlab Clinical Limited
| Country | Australia |
| State | NSW |
| City | Botany |
| Address | Building A |
| ZIP | 2019 |
| Phone | 61 2 8188 0311 |
| Website | https://www.medlab.co |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.
Q&A For Medlab Clinical Limited Stock
What is a current MDC.XA stock price?
Medlab Clinical Limited MDC.XA stock price today per share is 6.9 AUD.
How to purchase Medlab Clinical Limited stock?
You can buy MDC.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medlab Clinical Limited?
The stock symbol or ticker of Medlab Clinical Limited is MDC.XA.
How many shares does Medlab Clinical Limited have in circulation?
The max supply of Medlab Clinical Limited shares is 0.
What is Medlab Clinical Limited Price to Earnings Ratio (PE Ratio)?
Medlab Clinical Limited PE Ratio is now.
What was Medlab Clinical Limited earnings per share over the trailing 12 months (TTM)?
Medlab Clinical Limited EPS is -0.031 AUD over the trailing 12 months.